mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.17 |
0.006 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.006 |